Advertisement
ResearchIn-Press PreviewAutoimmunityCell biologyEndocrinology
Open Access | 10.1172/JCI195267
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by dos Santos, T. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Dai, X. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Jones, R. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Spigelman, A. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Mummey, H. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Ewald, J. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Ellis, C. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Lyon, J. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Smith, N. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Bautista, A. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Manning Fox, J. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Neff, N. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Detweiler, A. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Tan, M. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Arrojo e Drigo, R. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Xia, J. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Camunas-Soler, J. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by
Gaulton, K.
in:
PubMed
|
Google Scholar
|
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by Quake, S. in: PubMed | Google Scholar
1Department of Pharmacology, University of Alberta, Edmonton, Canada
2Department of Bioengineering, Stanford University, Stanford, United States of America
3Bioinformatics and Systems Biology Program, University of California San Diego, La Jolla, United States of America
4European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom
5Department of Pharmacology, Unviersity of Alberta, Edmonton, Canada
6Alberta Diabetes Institute, University of Alberta, Edmonton, Canada
7Chan Zuckerberg Biohub, San Francisco, United States of America
8Department of Molecular Physiology and Biophysics, Vanderbilt, Nashville, United States of America
9Department of Microbiology & Immunology, McGill University, Montreal, Canada
10Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, United States of America
11Department of Pediatrics, University of California San Diego, La Jolla, United States of America
12Department of Bioengineering, Stanford University, Stanford, United States of America
Find articles by
MacDonald, P.
in:
PubMed
|
Google Scholar
|
Published September 30, 2025 - More info
Type 1 diabetes (T1D) is characterized by the autoimmune destruction of most insulin-producing β-cells, along with dysregulated glucagon secretion from pancreatic α-cells. We conducted an integrated analysis that combines electrophysiological and transcriptomic profiling, along with machine learning, of islet cells from T1D donors. The few surviving β-cells exhibit altered electrophysiological properties and transcriptomic signatures indicative of increased antigen presentation, metabolic reprogramming, and impaired protein translation. In α-cells, we observed hyper-responsiveness and increased exocytosis, which are associated with upregulated immune signaling, disrupted transcription factor localization and lysosome homeostasis, as well as dysregulation of mTORC1 complex signaling. Notably, key genetic risk signals for T1D were enriched in transcripts related to α-cell dysfunction, including MHC class I, which were closely linked with α-cell dysfunction. Our data provide what we believe are novel insights into the molecular underpinnings of islet cell dysfunction in T1D, highlighting pathways that may be leveraged to preserve residual β-cell function and modulate α-cell activity. These findings underscore the complex interplay between immune signaling, metabolic stress, and cellular identity in shaping islet cell phenotypes in T1D.